Susquehanna International Group, LLP Merus N.V. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Merus N.V. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 27,240 shares of MRUS stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,240
Previous 112,100
75.7%
Holding current value
$1.08 Million
Previous $6.63 Million
79.49%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MRUS
# of Institutions
203Shares Held
62MCall Options Held
243KPut Options Held
300K-
Rtw Investments, LP New York, NY4.17MShares$166 Million3.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$135 Million3.17% of portfolio
-
Commodore Capital LP New York, NY3.35MShares$133 Million14.22% of portfolio
-
Wellington Management Group LLP Boston, MA2.89MShares$115 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$104 Million2.1% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.82B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...